InspireMD Reports Q3 Loss of $0.20/Share vs Loss of $0.22/Share Est., Sales of $273K vs $1.55M in Same Qtr. Last Year

Benzinga and Optionshouse have teamed up to provide everything you need for your premarket trading. If there is anything you need, please email us at: support@benzinga.com

Benzinga and OptionsHouse are separate and unaffiliated entities and do not share management or ownership. Investment products and services are offered by OptionsHouse, LLC.